trending Market Intelligence /marketintelligence/en/news-insights/trending/3wep5ObfxLwwMgNabIVVJg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Oncolix appoints board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Oncolix appoints board member

Oncolix Inc. appointed John Holaday as an independent board member.

Holaday's appointment makes him one of two independent directors, fulfilling an OTC-QB listing requirement.

Holaday is the co-founder, and most recently CEO, managing director and board member of QRxPharma Ltd.